[ad_1]
VANCOUVER, CANADA & TEL AVIV, ISRAEL – March 22, 2021 – Biotech company SaNOtize Research & Development Corp., (SaNOtize) today announced that it has received interim approval to sell its Nitric Oxide Nasal Spray (NONS), which protects users from viruses that enter the body through the upper nasal pathways, to the public in pharmacies in Israel, and has been registered to begin sales of NONS in New Zealand.
Read more here.
[ad_2]
Source link